The UTSA College of Business and College of Engineering are collaborating to offer a joint Master of Science degree program in Biomedical Technology Commercialization, beginning in the Spring 2020 semester.
“With advances in biomedical technologies and the need to have diverse and interdisciplinary knowledge for commercialization of developed technologies and devices, this program is highly attractive to students who have an undergraduate degree in engineering, sciences or business,” says Anson Ong, associate dean of administration and graduate studies for the UTSA College of Engineering.
Approved by the Texas Higher Education Coordinating Board on July 25, 2019, and administered in the Department of Biomedical Engineering and Chemical Engineering, the program is designed to provide students with a common platform of understanding in the areas of bioengineering and management of technology by taking nine semester credit hours of core courses from each college.
Students will subsequently be able to enhance their learning through an additional nine semester hours of elective courses from either college and finally by completing a final project in the area of biomedical technologies and commercialization.
“Contemporary biomedical firms need employees who are able to help them bridge the gap between product development and success in the market place,” says Kevin Grant, associate dean of undergraduate studies for the UTSA College of Business. “The new Master of Science in Biomedical Technology Commercialization will provide students with the skills they need to contribute to the success of these contemporary firms.”
At the completion of the degree program, students will have ample knowledge in the design of biomedical devices, technology commercialization, product development, intellectual properties, and the business knowledge to market those devices.